adenosine has been researched along with Acute Confusional Senile Dementia in 53 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.89) | 18.7374 |
| 1990's | 9 (16.98) | 18.2507 |
| 2000's | 12 (22.64) | 29.6817 |
| 2010's | 8 (15.09) | 24.3611 |
| 2020's | 23 (43.40) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Du, B; Du, Z; Fan, C; Jiang, Y; Li, H; Liang, M; Zhang, H; Zhang, Y | 1 |
| Austria, Q; Dai, Q; Gao, S; He, C; O'Donnell, JM; Pajdzik, K; Qin, L; Siedlak, SL; Tang, B; Wang, W; Xu, Y; Zhao, F; Zhu, X | 1 |
| Deng, Y; Gao, W; Liu, C; Liu, YL; Xiao, L; Zhu, H | 1 |
| Chen, L; Chen, Y; Jiao, K; Law, WJ; McMahon, L; Pati, S; Pizarro, D; Saggu, S; Wang, Q | 1 |
| Baltos, JA; Gregory, KJ; Hellyer, SD; May, LT; Trinh, PNH | 1 |
| Agostinho, P; Cunha, RA; Dias, L; Dias, R; Madeira, D; Tomé, ÂR | 1 |
| Cheng, W; Li, M; Peng, X; Yu, S; Zhang, L; Zhang, W; Zhou, C | 1 |
| Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S | 1 |
| Blum, D; Buée, L; Faivre, E; Launay, A; Lebouvier, T; Nebie, O; Vijaya Shankara, J | 1 |
| An, Y; Bai, X; Han, X; Lv, Y; Qiu, Z; Wang, P; Wang, X | 1 |
| Loh, D; Reiter, RJ | 1 |
| Ni, P; Pan, K; Zhao, B | 1 |
| Agostinho, P; Canas, PM; Cunha, RA; Lopes, CR; Lopes, JP; Silva, AC; Silva, HB | 1 |
| Dong, JH; Gao, LN; Gong, T; Hui, Y; Li, YY; Ma, Q; Wang, H; Zhang, T; Zhou, XR | 1 |
| Cheng, L; Hu, H; Li, H; Li, J; Li, X; Lu, Y; Shen, N; Tan, L; Wang, X; Xie, J | 1 |
| Agostinho, P; Canas, PM; Cunha, RA; Ferreira, SG; Gonçalves, FQ; Gonçalves, N; Lemos, C; Lopes, JP; Rial, D; Silva, AC; Silva, HB; Tomé, ÂR | 1 |
| Chen, S; Deng, Z; Kong, Y; Liang, X; Lv, N; Peng, Q; Wang, L; Yuan, J | 1 |
| Albasanz, JL; Griñán-Ferré, C; Martín, M; Pallàs, M; Sánchez-Melgar, A | 1 |
| Albasanz, JL; Martín, M; Pallàs, M; Sánchez-Melgar, A | 1 |
| Cai, Z; Huang, R; Li, Y; Ma, Y; Pan, L; Wu, H; Wu, X | 1 |
| Kim, P; Wu, S; Yang, M; Zhou, X | 1 |
| Allen, EG; Dai, Q; Duan, R; Guo, Z; He, C; Jin, P; Kang, Y; Li, Y; Pajdzik, K; Shafik, AM; Wu, H; Yao, B; Zhang, F | 1 |
| Albasanz, JL; Ballesteros-Yáñez, I; Castillo, CA; León-Navarro, DA; Martín, M | 1 |
| Abisambra, JF; Alvarez, VE; Ash, PEA; Boudeau, S; Cheng, JX; Crary, JF; Cruz, AL; Emili, A; Hovde, S; Jiang, L; Kanaan, N; Kuo, MH; Kwan, J; Lei, S; Li, H; Lin, W; Maziuk, BF; Murray, ME; Petrucelli, L; Song, J; van Vliet, E; Verma, M; Wolozin, B; Yang, Z; Zhang, C; Zhao, J | 1 |
| Barhum, Y; Ben-Zur, T; Danino, O; Fischer, B; Offen, D; Segal-Gavish, H; Shai, E; Varon, D | 1 |
| Blum, D; Buée, L; Chang, CP; Chen, HM; Cheng, SJ; Chern, Y; Faivre, E; Fang, JM; Kao, YH; Lai, HL; Lee, CC; Liao, YP; Lin, CJ | 1 |
| Allen, EG; Armstrong, MJ; Jin, P; Jin, Y | 1 |
| Hu, ZY; Wang, Q; Yan, R; Zhang, YX; Zhou, WX | 1 |
| Annese, A; Barak, M; D'Erchia, AM; Eisenberg, E; Khermesh, K; Levanon, EY; Picardi, E; Wachtel, C | 1 |
| Bae, N; Byeon, SE; Cho, JY; Hong, S; Kwon, M; Lee, SJ; Mook-Jung, I; Song, J | 1 |
| Buarque, CD; Felcman, J; Ramos, JM; Silva, AM; Tenório, T | 1 |
| Ferroni, S; Marchini, C; Ogata, T; Schubert, P | 1 |
| Angulo, E; Canela, EI; Casadó, V; Ferrer, I; Franco, R; Lluis, C; Mallol, J; Viñals, F | 1 |
| Selley, ML | 1 |
| Chao, MV; Lee, FS | 1 |
| Anrather, J; Carlson, GA; Frys, K; Iadecola, C; Park, L; Pitstick, R; Younkin, S; Zhou, P | 1 |
| Ahn Jo, S; Ahn, K; Jo, I; Kang, BH; Kim, DK; Kim, E; Kim, JH | 1 |
| da Silva, AL; Dall'Igna, OP; Hoffmann, A; Lara, DR; Souza, DO | 1 |
| Arendash, GW; Cracchiolo, JR; Jackson, EK; Rezai-Zadeh, K; Schleif, W; Shippy, D; Tan, J; Zacharia, LC | 1 |
| Boison, D | 1 |
| Pamplona, FA; Prediger, RD; Takahashi, RN | 1 |
| Bohl, J; Lemmer, B; Ohm, T; Schnecko, A; Witte, K | 1 |
| Dewar, D; Ikeda, M; Mackay, KB; McCulloch, J | 1 |
| Brunner, LC; Cotman, CW; Nguyen, L; Ułas, J | 1 |
| Kittner, B; Rössner, M; Rother, M | 1 |
| Ferroni, S; Marchini, C; McRae, A; Ogata, T; Rudolphi, K; Schubert, P | 1 |
| Ferroni, S; Marchini, C; Miyazaki, H; Ogata, T; Rudolphi, K; Schubert, P | 1 |
| Kapl, D; Rudolphi, KA | 1 |
| Ain, KB; Butterfield, DA; Varadarajan, S; Yatin, M; Yatin, SM | 1 |
| Exley, C; Korchazhkina, OV | 1 |
| Jaarsma, D; Korf, J; Sebens, JB | 1 |
| Kalaria, RN; Sromek, S; Unnerstall, JR; Wilcox, BJ | 1 |
| Freeman, SE; Lau, WM; Szilagyi, M | 1 |
12 review(s) available for adenosine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Adenosine receptor signalling in Alzheimer's disease.
Topics: Adenosine; Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Humans; Receptors, Purinergic P1 | 2022 |
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan | 2022 |
The role of adenosine A
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Humans; Receptor, Adenosine A2A; tau Proteins; Tauopathies | 2023 |
Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia.
Topics: Adenosine; Adenosine Triphosphate; Alzheimer Disease; Humans; Melatonin; Water | 2023 |
The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.
Topics: Adenosine; Alzheimer Disease; Caffeine; Humans; Protein Isoforms; Purinergic Agonists; Purinergic Antagonists; Receptors, Purinergic; Signal Transduction | 2021 |
Diverse and dynamic DNA modifications in brain and diseases.
Topics: Adenosine; Alzheimer Disease; Animals; Ataxia; Brain; Chromatin; Cytosine; DNA; DNA Methylation; Epigenesis, Genetic; Histones; Humans; Mice; Neurodegenerative Diseases; Parkinson Disease | 2019 |
Adenosine as a neuromodulator in neurological diseases.
Topics: Adenosine; Adenosine Kinase; Alzheimer Disease; Animals; Brain Diseases; Brain Ischemia; Epilepsy; Humans; Huntington Disease; Pain; Parkinson Disease; Schizophrenia; Synaptic Transmission | 2008 |
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.
Topics: Adenosine; Alzheimer Disease; Animals; Attention Deficit Disorder with Hyperactivity; Cognition Disorders; Disease Models, Animal; Humans; Learning; Memory; Parkinson Disease; Purinergic P1 Receptor Antagonists; Rats; Rats, Inbred SHR; Receptors, Purinergic P1 | 2008 |
Clinical trials in dementia with propentofylline.
Topics: Adenosine; Aged; Alzheimer Disease; Clinical Trials, Phase III as Topic; Dementia, Vascular; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Neuroprotective Agents; Randomized Controlled Trials as Topic; Xanthines | 1997 |
Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline.
Topics: Adenosine; Alzheimer Disease; Astrocytes; Calcium; Cyclic AMP; Homeostasis; Humans; Models, Biological; Molecular Mimicry; Neuroglia; Second Messenger Systems; Signal Transduction; Xanthines | 1997 |
Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference.
Topics: Adenosine; Alzheimer Disease; Astrocytes; Brain; Calcium; Cyclic AMP; Humans; Interleukin-1; Microglia; Models, Neurological; Neuroglia; Second Messenger Systems; Tumor Necrosis Factor-alpha | 1998 |
[New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)].
Topics: Adenosine; Alzheimer Disease; Animals; Cerebrovascular Circulation; Cognition Disorders; Dementia, Vascular; Dog Diseases; Dogs; Hemodynamics; Humans; Neuroprotective Agents; Phosphodiesterase Inhibitors; Xanthines | 1998 |
41 other study(ies) available for adenosine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Datasets as Topic; Dementia, Vascular; Female; Humans; Male; Methylation; Methyltransferases; RNA Processing, Post-Transcriptional; RNA, Messenger; snRNP Core Proteins | 2021 |
METTL3-dependent RNA m
Topics: Adenosine; Alzheimer Disease; Cell Cycle; Humans; Methyltransferases; RNA | 2021 |
Identification of the function and mechanism of m6A reader IGF2BP2 in Alzheimer's disease.
Topics: Adenosine; Alzheimer Disease; Databases, Genetic; Humans; RNA Processing, Post-Transcriptional; RNA-Binding Proteins | 2021 |
A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer's model.
Topics: Adenosine; Alzheimer Disease; Animals; Anticonvulsants; Epilepsy; Humans; Mice; Microfilament Proteins; Nerve Tissue Proteins; Receptor, Adenosine A1; RGS Proteins | 2022 |
Aβ
Topics: Adenosine; Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Calcium; Cells, Cultured; Peptide Fragments; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P2X7; Receptors, Purinergic P2Y1 | 2022 |
Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification.
Topics: Adenosine; Alzheimer Disease; Computational Biology; Humans; Methylation; RNA | 2022 |
Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease.
Topics: Adenosine; Alzheimer Disease; Databases, Factual; Humans; RNA | 2023 |
Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
Topics: Adenosine; Alzheimer Disease; Cysteine; Databases, Protein; Endopeptidases; Humans; Phenotype | 2023 |
Adenosine A
Topics: Adenosine; Alzheimer Disease; Animals; Memory Disorders; Mice; Neuronal Plasticity; Receptor, Adenosine A2A; Up-Regulation | 2023 |
Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease.
Topics: Adenosine; Alzheimer Disease; Humans; RNA; RNA Transport | 2023 |
N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease.
Topics: Adenosine; Alzheimer Disease; Animals; Memory Disorders; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Transgenic; MicroRNAs; Peptides; Receptors, N-Methyl-D-Aspartate; RNA, Circular | 2023 |
Synaptic and memory dysfunction in a β-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Alzheimer Disease; Animals; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A | 2019 |
Paeoniflorin exerts neuroprotective effects in a transgenic mouse model of Alzheimer's disease via activation of adenosine A
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Glucosides; Memory; Mice, Transgenic; Monoterpenes; Neuroprotective Agents; Receptor, Adenosine A1 | 2020 |
Adenosine and Metabotropic Glutamate Receptors Are Present in Blood Serum and Exosomes from SAMP8 Mice: Modulation by Aging and Resveratrol.
Topics: Adenosine; Aging; Alzheimer Disease; Animals; Blotting, Western; Chromatography, High Pressure Liquid; Exosomes; Male; Mice; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Metabotropic Glutamate; Resveratrol | 2020 |
Adenosine Metabolism in the Cerebral Cortex from Several Mice Models during Aging.
Topics: Adenosine; Aging; Alzheimer Disease; Animals; Cellular Senescence; Cerebral Cortex; Disease Models, Animal; Hippocampus; Humans; Inosine; Mice; Phosphorylation; Xanthine | 2020 |
ADeditome provides the genomic landscape of A-to-I RNA editing in Alzheimer's disease.
Topics: Adenosine; Alternative Splicing; Alzheimer Disease; Amnesia; Brain; Brain Mapping; Databases, Genetic; Gene Ontology; Humans; Inosine; MicroRNAs; Molecular Sequence Annotation; Nerve Tissue Proteins; Receptors, AMPA; RNA Editing; Transcriptome | 2021 |
N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer's disease.
Topics: Adenosine; Aging; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Drosophila; Drosophila Proteins; Humans; Methylation; Methyltransferases; Mice; Neurodegenerative Diseases; RNA Stability | 2021 |
Early Effects of the Soluble Amyloid β
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Female; Neurons; Peptide Fragments; Phospholipase C beta; Pregnancy; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Glutamate; Receptors, Neurotransmitter; Signal Transduction | 2021 |
Interaction of tau with HNRNPA2B1 and N
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Case-Control Studies; Cerebral Cortex; Disease Models, Animal; Disease Progression; Female; HEK293 Cells; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Male; Methylation; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Protein Aggregates; Protein Aggregation, Pathological; RNA; RNA Processing, Post-Transcriptional; Severity of Illness Index; tau Proteins | 2021 |
A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Antipsychotic Agents; Biocompatible Materials; Cells, Cultured; Cerebral Cortex; Copper; Disease Models, Animal; L-Lactate Dehydrogenase; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Phenothiazines; Platelet Aggregation; Presenilin-1; Zinc | 2017 |
Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Astrocytes; Cerebral Cortex; Cognitive Dysfunction; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Equilibrative Nucleoside Transporter 1; Glycogen Synthase Kinase 3 beta; Hippocampus; Memory Disorders; Mice, Transgenic; Neuronal Plasticity; Plaque, Amyloid; Presenilin-1; Receptor, Adenosine A2A; Synaptic Transmission | 2018 |
[Roles of adenosine receptors in Alzheimer's disease].
Topics: Adenosine; Alzheimer Disease; Humans; Neurotransmitter Agents; Receptors, Purinergic P1 | 2014 |
Reduced levels of protein recoding by A-to-I RNA editing in Alzheimer's disease.
Topics: Adenosine; Adenosine Deaminase; Alzheimer Disease; Epigenesis, Genetic; Frontal Lobe; High-Throughput Nucleotide Sequencing; Hippocampus; Humans; Inosine; Microfluidics; Polymerase Chain Reaction; RNA Editing; RNA Precursors; RNA-Binding Proteins; RNA, Double-Stranded; Temporal Lobe | 2016 |
Knock-down of protein L-isoaspartyl O-methyltransferase increases β-amyloid production by decreasing ADAM10 and ADAM17 levels.
Topics: ADAM Proteins; ADAM10 Protein; ADAM17 Protein; Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; HEK293 Cells; Humans; Membrane Proteins; Protein D-Aspartate-L-Isoaspartate Methyltransferase; RNA Interference; RNA, Small Interfering; Transfection | 2011 |
Molecular structure of tetraaqua adenosine 5'-triphosphate aluminium(III) complex: a study involving Raman spectroscopy, theoretical DFT and potentiometry.
Topics: Adenosine; Adenosine Triphosphate; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Humans; Models, Molecular; Organometallic Compounds; Potentiometry; Spectrum Analysis, Raman | 2013 |
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes.
Topics: 2-Chloroadenosine; Acetylcholine; Adenosine; Adrenergic Agonists; Alzheimer Disease; Animals; Astrocytes; Calcium; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Muscarinic Antagonists; Nicotinic Antagonists; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Muscarinic; Receptors, Nicotinic; Receptors, Purinergic | 2002 |
A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Blotting, Western; Brain; Case-Control Studies; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Flavonoids; Humans; Immunohistochemistry; Indoles; Male; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuroprotective Agents; Phosphorylation; Receptor, Adenosine A1; Receptors, Adenosine A2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Staining and Labeling; tau Proteins; Time Factors; Translocation, Genetic; Tubulin; Xanthines | 2003 |
Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cerebrovascular Disorders; Down-Regulation; Female; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Neuroprotective Agents; Predictive Value of Tests; S-Adenosylhomocysteine; Up-Regulation | 2004 |
Neurotrophin survival signaling mechanisms.
Topics: Adenosine; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Cell Survival; Hippocampus; Humans; Huntington Disease; Motor Neurons; Nerve Growth Factors; Neuropeptides; Neurotransmitter Agents; Pituitary Adenylate Cyclase-Activating Polypeptide; Prosencephalon; Receptor, trkA; Receptor, trkB; Receptors, G-Protein-Coupled; Signal Transduction | 2004 |
NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.
Topics: Acetylcholine; Adenosine; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Bradykinin; Calcimycin; Cerebrovascular Circulation; Female; Glycoproteins; Humans; Hyperemia; Laser-Doppler Flowmetry; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; NADPH Oxidase 2; NADPH Oxidases; Nerve Tissue Proteins; Nitric Oxide Donors; Oxidative Stress; Peptide Fragments; Phenanthridines; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Vibrissae; X Chromosome | 2005 |
ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.
Topics: Adenosine; Aged; Aged, 80 and over; Alleles; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Choline O-Acetyltransferase; Female; Genotype; Guanosine; Humans; Male; Middle Aged; Polymorphism, Genetic | 2006 |
Beta-amyloid treatment sensitizes mice to amphetamine-induced locomotion but reduces response to caffeine.
Topics: Adenosine; Adrenergic Agents; Alzheimer Disease; Amphetamine; Amyloid beta-Peptides; Animals; Avoidance Learning; Brain; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Glutamine; Injections, Intraventricular; Male; Mice; Motor Activity; Psychotic Disorders | 2004 |
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Brain; Caffeine; Cell Line, Tumor; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Memory Disorders; Memory, Short-Term; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Neuropsychological Tests; Peptide Fragments; Presenilin-1; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Treatment Outcome | 2006 |
Adenylyl cyclase activity in Alzheimer's disease brain: stimulatory and inhibitory signal transduction pathways are differently affected.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebellum; Colforsin; Enzyme Activation; Female; GTP-Binding Proteins; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Hippocampus; Humans; Male; Manganese; Middle Aged; Neurotransmitter Agents; Purinergic P1 Receptor Antagonists; Signal Transduction | 1994 |
Differential alterations in adenosine A1 and kappa 1 opioid receptors in the striatum in Alzheimer's disease.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Analgesics; Autopsy; Autoradiography; Benzeneacetamides; Caudate Nucleus; Choline O-Acetyltransferase; Corpus Striatum; Female; Humans; Male; Middle Aged; Putamen; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Purinergic; Reference Values; Tritium | 1993 |
Reduced density of adenosine A1 receptors and preserved coupling of adenosine A1 receptors to G proteins in Alzheimer hippocampus: a quantitative autoradiographic study.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Dizocilpine Maleate; Female; GTP-Binding Proteins; Hippocampus; Humans; Kinetics; Male; Organ Specificity; Pyramidal Tracts; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic; Tritium; Xanthines | 1993 |
Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cells, Cultured; Eflornithine; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Free Radical Scavengers; Free Radicals; Neurons; Oxidative Stress; Peptide Fragments; Polyamines; Rats; Rats, Sprague-Dawley; Spermidine Synthase; Spermine | 2001 |
Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP).
Topics: Adenosine; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzothiazoles; Fluorescent Dyes; Humans; Islet Amyloid Polypeptide; Organometallic Compounds; Suramin; Thiazoles | 2001 |
Reduction of adenosine A1-receptors in the perforant pathway terminal zone in Alzheimer hippocampus.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Female; Hippocampus; Humans; Male; Middle Aged; Neural Pathways; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Purinergic; Xanthines | 1991 |
Hippocampal adenosine A1 receptors are decreased in Alzheimer's disease.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Hippocampus; Humans; Middle Aged; Receptors, Purinergic; Tritium | 1990 |
Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors.
Topics: Action Potentials; Adenosine; Alzheimer Disease; Aminoacridines; Animals; Carbachol; Guinea Pigs; Heart; In Vitro Techniques; Myocardial Contraction; Phenylisopropyladenosine; Potassium Channels; Quinuclidinyl Benzilate; Receptors, Muscarinic; Receptors, Purinergic; Tacrine | 1988 |